Home Authors Posts by Tess Egginton

Tess Egginton

Tess Egginton
1445 POSTS 0 COMMENTS
http://www.pbiforum.net

Roche to acquire Good Therapeutics for $250m

agreement

Duke Street agrees to sell Medi-Globe Group to DCC Healthcare

Manuka honey could help to clear deadly drug-resistant lung infection

Advanco partners with Vantage to deliver the first interoperable pharmaceutical traceability...

Bharat Biotech’s intranasal COVID-19 vaccine receives approval for emergency use in...

Forxiga approved in China for the treatment of chronic kidney disease

Azurity Pharmaceuticals receives FDA approval for Konvomep

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle...

FDA Orphan Drug Designation granted to Maze Therapeutics’ Pompe disease treatment

CanSinoBIO’s Convidecia Air COVID-19 vaccine receives approval in China as booster

1...112113114...145Page 113 of 145

News

Maxion Therapeutics raises $72m in oversubscribed Series A financing to advance KnotBody pipeline and...

Maxion Therapeutics, a biotechnology company developing antibody-based KnotBody drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, has raised $72 million in...

Araris Biotech to be acquired by Taiho Pharmaceutical for up to $1.14bn

4BIO Capital's portfolio company, Araris Biotech, a Swiss oncology biotech company developing next-generation antibody drug conjugates (ADCs), has entered into an agreement to be...

Atsena Therapeutics granted U.S. FDA Fast Track designation for gene therapy to treat X-linked...

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Atsena Therapeutics' ATSN-201 for the treatment of X-linked retinoschisis (XLRS). ATSN-201, a...

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks